PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35093482-5	2022	Mitigation of radiation-induced pneumonitis with the ACE-inhibitor lisinopril was evaluated in the 13.5 Gy rat PBI model.	Lisinopril	67-77	angiotensin I converting enzyme	Rattus norvegicus	53-56	
35093482-10	2022	Lisinopril abrogated radiation-induced increases in BALF MCP-1 (CCL2) and MIP-1alpha cytokine levels (p < 0.0001).	Lisinopril	0-10	C-C motif chemokine ligand 2	Homo sapiens	57-62	
35093482-10	2022	Lisinopril abrogated radiation-induced increases in BALF MCP-1 (CCL2) and MIP-1alpha cytokine levels (p < 0.0001).	Lisinopril	0-10	C-C motif chemokine ligand 2	Homo sapiens	64-68	
35093482-10	2022	Lisinopril abrogated radiation-induced increases in BALF MCP-1 (CCL2) and MIP-1alpha cytokine levels (p < 0.0001).	Lisinopril	0-10	C-C motif chemokine ligand 3	Homo sapiens	74-84	
35093482-11	2022	Treatment with lisinopril reduced both ACE expression (p=0.006) and frequency of CD45+CD11b+ lung myeloid cells (p=0.004).	Lisinopril	15-25	angiotensin I converting enzyme	Homo sapiens	39-42	
35093482-11	2022	Treatment with lisinopril reduced both ACE expression (p=0.006) and frequency of CD45+CD11b+ lung myeloid cells (p=0.004).	Lisinopril	15-25	integrin subunit alpha M	Homo sapiens	86-91	
35093482-12	2022	In vitro, radiation injury acutely increased ACE activity (p=0.045) and reactive oxygen species (ROS) generation (p=0.004) in human monocytes, whereas treatment with lisinopril blocked radiation-induced increases in both ACE and ROS.	Lisinopril	166-176	angiotensin I converting enzyme	Homo sapiens	45-48	
35093482-12	2022	In vitro, radiation injury acutely increased ACE activity (p=0.045) and reactive oxygen species (ROS) generation (p=0.004) in human monocytes, whereas treatment with lisinopril blocked radiation-induced increases in both ACE and ROS.	Lisinopril	166-176	angiotensin I converting enzyme	Homo sapiens	221-224